57 related articles for article (PubMed ID: 15058522)
21. Mitochondrial dysfunction in inflammatory bowel disease.
Novak EA; Mollen KP
Front Cell Dev Biol; 2015; 3():62. PubMed ID: 26484345
[TBL] [Abstract][Full Text] [Related]
22. Death-associated protein kinase: A molecule with functional antagonistic duality and a potential role in inflammatory bowel disease (Review).
Steinmann S; Scheibe K; Erlenbach-Wuensch K; Neufert C; Schneider-Stock R
Int J Oncol; 2015 Jul; 47(1):5-15. PubMed ID: 25963636
[TBL] [Abstract][Full Text] [Related]
23. Ulcerative colitis-associated colorectal cancer.
Yashiro M
World J Gastroenterol; 2014 Nov; 20(44):16389-97. PubMed ID: 25469007
[TBL] [Abstract][Full Text] [Related]
24. Inflammatory colonic carcinogenesis: a review on pathogenesis and immunosurveillance mechanisms in ulcerative colitis.
Scarpa M; Castagliuolo I; Castoro C; Pozza A; Scarpa M; Kotsafti A; Angriman I
World J Gastroenterol; 2014 Jun; 20(22):6774-85. PubMed ID: 24944468
[TBL] [Abstract][Full Text] [Related]
25. Chemistry meets biology in colitis-associated carcinogenesis.
Mangerich A; Dedon PC; Fox JG; Tannenbaum SR; Wogan GN
Free Radic Res; 2013 Nov; 47(11):958-86. PubMed ID: 23926919
[TBL] [Abstract][Full Text] [Related]
26. The role of polymorphonuclear leukocyte trafficking in the perpetuation of inflammation during inflammatory bowel disease.
Brazil JC; Louis NA; Parkos CA
Inflamm Bowel Dis; 2013 Jun; 19(7):1556-65. PubMed ID: 23598816
[TBL] [Abstract][Full Text] [Related]
27. Inflammatory bowel disease: mechanisms, redox considerations, and therapeutic targets.
Biasi F; Leonarduzzi G; Oteiza PI; Poli G
Antioxid Redox Signal; 2013 Nov; 19(14):1711-47. PubMed ID: 23305298
[TBL] [Abstract][Full Text] [Related]
28. Chronic epithelial NF-κB activation accelerates APC loss and intestinal tumor initiation through iNOS up-regulation.
Shaked H; Hofseth LJ; Chumanevich A; Chumanevich AA; Wang J; Wang Y; Taniguchi K; Guma M; Shenouda S; Clevers H; Harris CC; Karin M
Proc Natl Acad Sci U S A; 2012 Aug; 109(35):14007-12. PubMed ID: 22893683
[TBL] [Abstract][Full Text] [Related]
29. Acute sensitization of colon cancer cells to inflammatory cytokines by prophase arrest.
Kuratnik A; Senapati VE; Verma R; Mellone BG; Vella AT; Giardina C
Biochem Pharmacol; 2012 May; 83(9):1217-28. PubMed ID: 22306067
[TBL] [Abstract][Full Text] [Related]
30. Pathogenesis and biomarkers of carcinogenesis in ulcerative colitis.
Thorsteinsdottir S; Gudjonsson T; Nielsen OH; Vainer B; Seidelin JB
Nat Rev Gastroenterol Hepatol; 2011 Jun; 8(7):395-404. PubMed ID: 21647200
[TBL] [Abstract][Full Text] [Related]
31. Nuclear factor-erythroid 2-related factor 2 as a chemopreventive target in colorectal cancer.
Saw CL; Kong AN
Expert Opin Ther Targets; 2011 Mar; 15(3):281-95. PubMed ID: 21261563
[TBL] [Abstract][Full Text] [Related]
32. Pathobiology of the neutrophil-intestinal epithelial cell interaction: role in carcinogenesis.
Hofman PM
World J Gastroenterol; 2010 Dec; 16(46):5790-800. PubMed ID: 21154999
[TBL] [Abstract][Full Text] [Related]
33. The Mutyh base excision repair gene influences the inflammatory response in a mouse model of ulcerative colitis.
Casorelli I; Pannellini T; De Luca G; Degan P; Chiera F; Iavarone I; Giuliani A; Butera A; Boirivant M; Musiani P; Bignami M
PLoS One; 2010 Aug; 5(8):e12070. PubMed ID: 20706593
[TBL] [Abstract][Full Text] [Related]
34. Clinical presentation and diagnosis of intestinal adenocarcinoma in Crohn's disease: analysis of clinical predictors and of the life-time risk.
Ruffolo C; Scarpa M; Polese L; D'Amico FE; Boetto R; Pozza A; D'Incà R; Checchin D; Sturniolo GC; Bassi N; Angriman I
J Gastrointest Surg; 2010 Nov; 14(11):1746-51. PubMed ID: 20628906
[TBL] [Abstract][Full Text] [Related]
35. Colitis-associated colorectal cancer driven by T-bet deficiency in dendritic cells.
Garrett WS; Punit S; Gallini CA; Michaud M; Zhang D; Sigrist KS; Lord GM; Glickman JN; Glimcher LH
Cancer Cell; 2009 Sep; 16(3):208-19. PubMed ID: 19732721
[TBL] [Abstract][Full Text] [Related]
36. [Intraepithelial neoplasia/dysplasia - histopathology in ulcerative colitis].
Baretton GB; Aust DE
Pathologe; 2008 Nov; 29 Suppl 2():280-5. PubMed ID: 18820923
[TBL] [Abstract][Full Text] [Related]
37. Ulcerative colitis is a disease of accelerated colon aging: evidence from telomere attrition and DNA damage.
Risques RA; Lai LA; Brentnall TA; Li L; Feng Z; Gallaher J; Mandelson MT; Potter JD; Bronner MP; Rabinovitch PS
Gastroenterology; 2008 Aug; 135(2):410-8. PubMed ID: 18519043
[TBL] [Abstract][Full Text] [Related]
38. Oxidative DNA damage and antioxidant activity in patients with inflammatory bowel disease.
Dincer Y; Erzin Y; Himmetoglu S; Gunes KN; Bal K; Akcay T
Dig Dis Sci; 2007 Jul; 52(7):1636-41. PubMed ID: 17393334
[TBL] [Abstract][Full Text] [Related]
39. Colon cancer and the immune system: the role of tumor invading T cells.
Waldner M; Schimanski CC; Neurath MF
World J Gastroenterol; 2006 Dec; 12(45):7233-8. PubMed ID: 17143936
[TBL] [Abstract][Full Text] [Related]
40. Decreased total and corrected antioxidant capacity in patients with inflammatory bowel disease.
Koutroubakis IE; Malliaraki N; Dimoulios PD; Karmiris K; Castanas E; Kouroumalis EA
Dig Dis Sci; 2004 Sep; 49(9):1433-7. PubMed ID: 15481315
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
